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Sir,
We thank the correspondents for their interest in our study
(Schoemaker et al, 2005). Professors Hardell and Mild ask
about several design features of the study, to which we reply as
follows.
Controls in the four Nordic centres in our study were recruited
from population registers and from the UK centres were selected
from general practitioner practices. The latter are a representative
source of population-based controls as approximately 98% of the
UK population is registered with a GP (OPCS, 1992).
With exception of Finland, where interviews were nearly all at a
hospital, interviews were carried out at a location chosen by the
participant, with interviewers travelling to these locations, and at a
time of interview most convenient to the participant, to make the
interview as stress-free as possible. Blinding interviewers to
participants’ case–controls status is impossible in personal
interviews, but interviewers were trained to treat everyone
equally and information on mobile phone use was collected with
a highly structured and standardized computer-assisted interview.
Exposure indices were calculated with computer programs
regardless of case–control status. Excluding the small proportion
of subjects who were interviewed over the telephone, mainly in
Norway, did not materially affect the results. Contrary to the
correspondents’ assertion, the Northern part of Sweden was
not part of the study region of the Swedish study. Patients or
controls at distant addresses in the study were not omitted from
the study.
With regard to Table 4 in our paper, we refer Professors Hardell
and Mild to the Methods section and the table’s footnote
describing the definition of the reference groups and the inclusion
of bilateral phone users in both the ipsilateral and contralateral
analyses.
We did not include cordless phones in our analysis because they
have a lower power output than mobile phones (IEGMP, 2000), but
several other Interphone papers did include them (e.g. Lonn et al,
2004; Schu ¨z et al, 2006), and the pooled 13-country Interphone
analyses will be able to explore whether the exclusion of cordless
phones makes a material difference to the results.
Provision of funds to the study investigators was via a firewall
and was governed by legally binding agreements that guaranteed
the study’s complete scientific independence. The research was
initiated, conducted and published without reference to any of
the funding agencies. It is hard to see how a contractual clause that
the funders may be informed a maximum of 7 days before
publication of the results under strict terms of confidentiality
infringes on this.
Dr Hocking points out that misclassification in exposure
assessment could have diluted a possible increased risk of
acoustic neuroma among mobile phone users. We explain, in the
paper, that misclassification could have diluted any real trend
of risk with cumulative number of calls or hours of use, but
as Dr Hocking points out himself, information on recall of year
of first phone use is less likely to be seriously erroneous. Part
of the reason for our conclusion of ‘no substantial risk in the
first decade after starting mobile phone use’ was exactly this
information.
Dr Milham focuses on the decreased odds ratios in relation
to recent phone use, and the possibility of control selection
bias. We had discussed in our paper the potential for this bias,
but also the potential for other biases, some of which might
explain the decreased relative risks after recent use. As there
is more than one explanation for a diminished relative risk
after short-term use, and uncertainty on the extent and presence
of the various biases affecting the relative risk, we do not think
that one can justifiably draw any conclusions about a ‘future
epidemic’, but rather, as we stated, that ‘an increase in risk
after longer-term use or after a longer lag period could not be
ruled out’. Published online 28 March 2006
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